News
Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...
Designed specifically for big AI projects, Gefion - named after the Norse goddess of fertility - was funded to the tune of ...
Suddenly, GLP-1 drugs like Ozempic, Wegovy and Mounjaro are everywhere, promising rapid weight loss by blunting appetite and ...
Dr William Li, whose book Eat to Beat Your Diet is a New York Times bestseller, says the most dangerous type of fat is ...
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...
The FDA is warning patients about “counterfeit” Ozempic. Drug manufacturer Novo Nordisk seized “several hundred units” from ...
A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results